FIRE & ICE Complication Predictor

Clinical calculation support · Verify results before clinical use

Clinical risk assessment status

A numerical complication estimate is unavailable until a validated prediction equation can be verified.

Calculation suspended

What is needed to reactivate the calculator?

Provide a verifiable publication or supplement containing the exact outcome definition, predictor coding, regression coefficients (including intercept), and any required calibration information. The equation can then be checked against the source before numerical output is restored.

No patient information is collected or submitted by this page. The FIRE AND ICE trial is evidence comparing ablation strategies; the trial publication alone does not establish the placeholder equation in the supplied code as a validated individual complication-risk model.

Clinical context

The FIRE AND ICE trial compared cryoballoon with radiofrequency ablation in patients with symptomatic, drug-refractory paroxysmal atrial fibrillation. Its primary safety endpoint was a composite of death, cerebrovascular events, or serious treatment-related adverse events.

Trial findingReported result
Participants randomized762
Primary safety endpoint, cryoballoon40 events; 1-year Kaplan–Meier estimate 10.2%
Primary safety endpoint, radiofrequency51 events; 1-year Kaplan–Meier estimate 12.8%
Between-group comparisonHR 0.78 (95% CI 0.52–1.18); P=0.24

These are trial-level results for the published composite endpoint and follow-up period. They must not be presented as an individualized risk estimate for a particular patient or as a direct substitute for a validated prediction model.

Implementation review

Variables in the supplied source

  • Age (years)
  • Gender, coded male = 1 and female = 0
  • Body mass index (kg/m²)
  • Left atrial diameter (mm)
  • Procedure type, cryoballoon = 1 and radiofrequency = 0

Why the output is withheld

The supplied code sets coefficients to 0.03, 0.50, 0.04, 0.02, and −0.40, with an intercept of −5.0, and comments that these are placeholders. No source supporting those values was provided. They are not used in this redesigned page.

Clinical use

Discuss procedural risks using the endpoint definitions and evidence relevant to the planned procedure, patient characteristics, local outcomes, and operator/team experience. Do not infer a risk category from this suspended calculator.

References

Kuck KH, Brugada J, Fürnkranz A, et al.; FIRE AND ICE Investigators. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. New England Journal of Medicine. 2016;374:2235–2245. DOI: 10.1056/NEJMoa1602014. PMID: 27042964.
Kuck KH, Brugada J, Schlüter M, et al. The FIRE AND ICE Trial: What We Know, What We Can Still Learn, and What We Need to Address in the Future. Journal of the American Heart Association. 2018;7:e010777. DOI: 10.1161/JAHA.118.010777. PMID: 30561258.
Clinical disclaimer: This page provides context about published trial evidence and explains why the supplied prediction equation is unavailable. It does not calculate individual risk and is not a substitute for clinical judgement, informed consent, local protocols, or a validated risk model.